journal article·2015-06-08Open access

S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated Urinary Tract Infections

Alessandro Colletta, Jianfeng Wu, Yaqi Wo, Michael Kappler, Hao Chen, Chuanwu Xi, Mark E. Meyerhoff

Abstract

High Resolution Image Download MS PowerPoint Slide Urinary Foley catheters are utilized for management of hospitalized patients and are associated with high rates of urinary tract infections (UTIs). Nitric oxide (NO) potently inhibits microbial biofilm formation, which is the primary cause of catheter associated UTIs (CAUTIs). Herein, commercial silicone Foley catheters are impregnated via a solvent swelling method with S -nitroso- N -acetyl-D-penicillamine (SNAP), a synthetic NO donor that exhibits long-term NO release and stability when incorporated into low water-uptake polymers. The proposed catheters generate NO surface-fluxes >0.7 × 10 –10 mol min –1 cm –2 for over one month under physiological conditions, with minimal SNAP leaching. These biomedical devices are demonstrated to significantly decrease formation of biofilm on the surface of the catheter tubings over 3, 7, and 14 day periods by microbial species ( Staphylococcus epidermidis and Proteus mirabilis ) commonly causing CAUTIs. Toxicity assessment demonstrates that the SNAP-impregnated catheters are fully biocompatible, as extracts of the catheter tubings score 0 on a 3-point grading scale using an accepted mouse fibroblast cell-line toxicity model. Consequently, SNAP-impregnated silicone Foley catheters can likely provide an efficient strategy to greatly reduce the occurrence of nosocomial CAUTIs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Urinary Tract Infections Management · Urinary Bladder and Prostate Research · Antibiotic Resistance in Bacteria

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biocrede Inc., Plymouth, Michigan 48170, United States

Funding

National Institute of Diabetes and Digestive and Kidney Diseases

References (57)

Show source-provided references
1. 10.2165/00003495-200565020-0000310.2165/00003495-200565020-00003 ↗
2. 10.1086/65791210.1086/657912 ↗
3. 10.3201/eid0702.70034210.3201/eid0702.700342 ↗
4. 10.1086/65048210.1086/650482 ↗
5. 10.1016/j.ajic.2011.07.01810.1016/j.ajic.2011.07.018 ↗
6. 10.1086/50196410.1086/501964 ↗
7. 10.3201/eid0702.70027710.3201/eid0702.700277 ↗
8. 10.1016/S0966-842X(00)01913-210.1016/S0966-842X(00)01913-2 ↗
9. 10.1128/CMR.00019-0710.1128/CMR.00019-07 ↗
10. 10.1007/s10096-013-1935-410.1007/s10096-013-1935-4 ↗
11. 10.1099/jmm.0.46404-010.1099/jmm.0.46404-0 ↗
12. 10.1038/ncpuro123110.1038/ncpuro1231 ↗
13. 10.1186/2047-2994-3-2310.1186/2047-2994-3-23 ↗
14. 10.1016/j.jhin.2005.01.02610.1016/j.jhin.2005.01.026 ↗
15. 10.3310/hta1647010.3310/hta16470 ↗
16. 10.1097/QCO.000000000000003110.1097/QCO.0000000000000031 ↗
17. 10.1146/annurev.immunol.15.1.32310.1146/annurev.immunol.15.1.323 ↗
18. 10.1016/j.biomaterials.2011.06.07510.1016/j.biomaterials.2011.06.075 ↗
19. 10.1039/c2cs15272j10.1039/c2cs15272j ↗
20. 10.1128/JB.00975-0910.1128/JB.00975-09 ↗
21. 10.1016/j.biomaterials.2012.07.02710.1016/j.biomaterials.2012.07.027 ↗
22. 10.1021/am406066a10.1021/am406066a ↗
23. 10.1039/c2ra20853a10.1039/c2ra20853a ↗
24. 10.1128/JB.00779-0610.1128/JB.00779-06 ↗
25. 10.1016/j.biomaterials.2013.05.06310.1016/j.biomaterials.2013.05.063 ↗
26. 10.1021/ac034671210.1021/ac0346712 ↗
27. 10.1093/jac/43.4.44110.1093/jac/43.4.441 ↗
28. 10.1111/j.1751-1097.1994.tb05065.x10.1111/j.1751-1097.1994.tb05065.x ↗
29. 10.1562/0031-8655(2000)0710273PGMRTR2.0.CO210.1562/0031-8655(2000)0710273PGMRTR2.0.CO2 ↗
30. 10.1021/ja039466i10.1021/ja039466i ↗
31. 10.1002/jbm.b.3156710.1002/jbm.b.31567 ↗
32. Stephens A. D. · Q. J. Med. · 1971 · 40 · 355
33. 10.1021/nn202054f10.1021/nn202054f ↗
34. 10.1002/smll.20120179810.1002/smll.201201798 ↗
35. 10.1086/32297210.1086/322972 ↗
36. 10.1016/j.ijantimicag.2006.05.01210.1016/j.ijantimicag.2006.05.012 ↗
37. 10.2217/fmb.10.5610.2217/fmb.10.56 ↗
38. 10.1038/nrmicro82110.1038/nrmicro821 ↗
39. Mack, D.; Davies, A. P.; Harris, L. G.; Jeeves, R.; Pascoe, B.; Knobloch, J. K.; Rohde, H.; Wilkinson, T. S.Biomaterials Associated Infection;Moriarty, T. F.; Zaat, S. A. J.; Busscher, H. J., Eds.Springer:New York, 2013; pp25–57.10.1007/978-1-4614-1031-7_2 ↗
40. 10.1155/2013/91892110.1155/2013/918921 ↗
41. 10.3390/ijerph11050461910.3390/ijerph110504619 ↗
42. 10.1128/AAC.00126-1110.1128/AAC.00126-11 ↗
43. 10.1128/AAC.49.6.2467-2473.200510.1128/AAC.49.6.2467-2473.2005 ↗
44. 10.1128/AAC.46.3.900-903.200210.1128/AAC.46.3.900-903.2002 ↗
45. 10.1093/jac/22.6.77710.1093/jac/22.6.777 ↗
46. 10.1128/AAC.47.1.317-323.200310.1128/AAC.47.1.317-323.2003 ↗
47. 10.1128/CMR.00019-0710.1128/CMR.00019-07 ↗
48. 10.1099/jmm.0.46123-010.1099/jmm.0.46123-0 ↗
49. 10.1099/jmm.0.012419-010.1099/jmm.0.012419-0 ↗
50. 10.1111/j.1574-695X.2007.00285.x10.1111/j.1574-695X.2007.00285.x ↗
51. 10.1111/j.1574-695X.2007.00284.x10.1111/j.1574-695X.2007.00284.x ↗
52. 10.1021/mp100248e.Synergy10.1021/mp100248e.Synergy ↗
53. 10.1128/AAC.00718-0910.1128/AAC.00718-09 ↗
54. 10.1016/S0090-4295(99)00288-510.1016/S0090-4295(99)00288-5 ↗
55. Anderson G. G. · Curr. Top. Microbiol. Immunol. · 2008 · 322 · 85
56. 10.1016/j.bbrc.2010.01.08310.1016/j.bbrc.2010.01.083 ↗
57. 10.1038/nature0391210.1038/nature03912 ↗